 |
|
| | An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells. |
| Previous Definitions: | HPV vaccine, HRT, HSIL, HSP, HTLV-1 | | Next Definitions: | Hu3S193, HuAFP31, Huang Lian, huC242-DM4, HuHMFG1 |
|
|
